The Global Demand for Global Amyotrophic Lateral Sclerosis Treatment Market in Terms of revenue was worth of USD 316.01 Million in 2020 and is expected to reach USD 436.17 Million in 2027, growing at a CAGR of 5.52% from 2021 to 2027.
The global amyotrophic lateral sclerosis treatment market is expected to grow at a significant growth rate due to number of driving factors.
Get Sample Copy of The Report@ https://brandessenceresearch.com/requestSample/PostId/1465
** Sample pages for this report are immediately accessible upon request. **
Scope of Amyotrophic Lateral Sclerosis Treatment Market:
Amyotrophic lateral sclerosis (ALS) is a nervous system disease that progressively degenerate the muscles and impacts physical body function. The disease is also recognized as motor neuron or Lou Gehrig's disease. The ALS mostly happens between 40-60 age groups and sometimes it can develop in early age also due to inheritance of the genetic mutation. The disease leads to the damage of nerve cells, brain and spinal cord which impact the difficulty in breathing, swallowing, speaking, and mobility. This disease is mostly of two types depending upon its cause which are sporadic and familial. The main cause of developing the ALS disease is disorganized immune response, chemical imbalance with higher levels of glutamate in the body, mishandling of proteins and some of the risk factors includes exposure to viral agents, vigorous physical activity, and trauma. Currently, no cure available for the treatment of the ALS disease but the drugs, advanced stem cell therapy and certain physical therapy can reduce the symptoms of the disease.
Global Amyotrophic Lateral Sclerosis Treatment Market: By Type
Sporadic ALS
Familial ALS
Global Amyotrophic Lateral Sclerosis Treatment Market: By Treatment
Medication
Riluzole
Edaravone
Nuedexta
Physical Therapy
Respiratory Therapy
Speech Therapy
Others
Global Amyotrophic Lateral Sclerosis Treatment Market: By End User
Hospitals
Specialty Centers
Others
Global Amyotrophic Lateral Sclerosis Treatment Market: Market Player Analysis
Mitsubishi Tanabe Pharma Corporation
Sun Pharmaceutical Industries Ltd.
CORESTEM, Inc
BrainStorm Cell Limited
Amylyx Pharmaceuticals Inc.
AB Science
Ionis Pharmaceuticals
Biohaven Pharmaceutical
Biogen
Others
Get Full Report :@ https://brandessenceresearch.com/healthcare/amyotrophic-lateral-sclerosis-treatment-market